World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
69517
World Ranking
7164
National Ranking
698

Overview

Mark Sculpher is affiliated with the University of York in the United Kingdom. Their research spans the intersection of medicine and economics, with a focus on health systems, economic evaluations, and quality of life. The primary fields of study include Medicine and Economics, Econometrics and Finance.

The scientist's work covers multiple subfields, notably:

  • Economics and Econometrics
  • General Health Professions
  • Pediatrics, Perinatology and Child Health
  • Infectious Diseases
  • Pulmonary and Respiratory Medicine

Key research topics addressed in their publications include:

  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy
  • Healthcare Cost, Quality, Practices
  • Healthcare Policy and Management
  • Global Maternal and Child Health
  • Global Health Care Issues
  • Antibiotic Use and Resistance

Sculpher has contributed to numerous research articles published in several frequent venues such as:

  • Value in Health
  • PharmacoEconomics
  • Health Economics
  • Applied Health Economics and Health Policy
  • Medical Decision Making

Recent notable papers include:

  • The Lancet Commission on prostate cancer: planning for the surge in cases, 2024, The Lancet
  • Economic analysis of the prevalence and clinical and economic burden of medication error in England, 2020, BMJ Quality & Safety
  • Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk, 2020, BMJ Open
  • Developing the EQ-5D-5L Value Set for Uganda Using the 'Lite' Protocol, 2021, PharmacoEconomics
  • Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?, 2021, Value in Health

Collaborative research is a significant aspect of Sculpher's career. Frequent co-authors include:

  • Beth Woods
  • Paul Revill
  • Karl Claxton
  • Simon Walker
  • Jessica Ochalek

The scientist's work integrates economic analysis and health policy perspectives, addressing critical issues in healthcare practices, pharmaceutical economics, and antimicrobial resistance. This multi-disciplinary approach is reflected in the variety of topics and journals in which they publish.

Best Publications

  • Methods for the Economic Evaluation of Health Care Programmes

    Michael F. Drummond;Mark J. Sculpher;Karl Claxton;Greg L. Stoddart

  • Decision Modelling for Health Economic Evaluation

    Andrew Briggs;Karl Claxton;Mark J Sculpher

  • Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine

    Gillian D. Sanders;Peter J. Neumann;Anirban Basu;Dan W. Brock

  • Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses.

    R Fitzpatrick;E Shortall;M Sculpher;D Murray

  • Representing uncertainty: the role of cost-effectiveness acceptability curves.

    Elisabeth Fenwick;Karl Claxton;Mark Sculpher

  • Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

    Karl Philip Claxton;Stephen Martin;Marta O Soares;Nigel Rice

  • Estimating mean QALYs in trial-based cost-effectiveness analysis : the importance of controlling for baseline utility

    Andrea Manca;Neil Hawkins;Mark J. Sculpher

  • Country-level cost effectiveness thresholds: initial estimates and the need for further research

    Beth Woods;Paul Revill;Mark Sculpher;Karl Claxton

  • Review of guidelines for good practice in decision-analytic modelling in health technology assessment

    Z Philips;L Ginnelly;M Sculpher;K Claxton

  • Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial

    R.M. Greenhalgh;L.C. Brown;D. Epstein;G.P.S. Kwong

  • Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.

    Andrew H. Briggs;Milton C. Weinstein;Elisabeth A. L. Fenwick;Jonathan Karnon

  • Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

    Andrew H. Briggs;Milton C. Weinstein;Elisabeth A.L. Fenwick;Jonathan Karnon

  • Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment: A Review and Consolidation of Quality Assessment

    Zoë Philips;Laura Bojke;Mark Sculpher;Karl Claxton

  • Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis

    Andrew Briggs;Mark Sculpher;Martin Buxton

  • Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

    Charlotte E Coles;Clare L Griffin;Anna M Kirby;Jenny Titley

  • Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra

    Karl Claxton;Mark Sculpher;Chris McCabe;Andrew Briggs

  • A rational framework for decision making by the National Institute For Clinical Excellence (NICE)

    Karl Claxton;Mark Sculpher;Michael Drummond

  • Whither trial-based economic evaluation for health care decision making?

    Mark J. Sculpher;Karl Claxton;Mike Drummond;Chris McCabe

  • Generalisability in economic evaluation studies in healthcare: a review and case studies.

    Sculpher Mj;Pang Fs;Manca A;Drummond Mf

  • Bayesian methods for evidence synthesis in cost-effectiveness analysis

    A. E. Ades;Mark Sculpher;Alex Sutton;Keith Abrams

Frequent Co-Authors

Karl Claxton
Karl Claxton University of York
Andrew Briggs
Andrew Briggs University of Glasgow
Keith R. Abrams
Keith R. Abrams University of Leicester
Michael Drummond
Michael Drummond University of York
Nigel Rice
Nigel Rice University of York
Peter C. Smith
Peter C. Smith Imperial College London
Nancy Devlin
Nancy Devlin University of Melbourne
Diana M. Gibb
Diana M. Gibb University College London
John Brazier
John Brazier University of Sheffield
Andrew J. Vickers
Andrew J. Vickers Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to a variety of online healthcare degrees and specialized career pathways. If you’re considering leadership roles, an online healthcare administration degree can prepare you for management roles in hospitals, clinics, and public health organizations.

For those aiming for advanced roles, the master's in healthcare administration online offers in-depth training in healthcare policy, finance, and operations. These degrees are ideal for professionals seeking to move into executive positions or oversee specialized facilities.

Nursing professionals can take the next step by enrolling in msn to dnp programs online, focusing on clinical leadership and evidence-based practice. Doctoral-level pharmacists also have flexible options; online pharmd programs enable working pharmacists to advance without pausing their careers.

These diverse online programs help students gain critical skills, improve career prospects, and adapt to the evolving healthcare landscape—while enjoying the convenience and affordability of remote learning.

Best Scientists Citing Mark Sculpher

Trending Scientists